The Association of the Polymorphic Marker of +795 G>A in the Adiponectin Receptor 2 Gene with Biopsy-confirmed Metabolic Dysfunction-associated Steatotic Liver Disease
DOI:
https://doi.org/10.15403/jgld-6326Keywords:
Adiponectin, ADIPOR2, MASLD, rs16928751, variantAbstract
Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) with the prevalence of around 25% is the most prevailing cause of chronic liver disease. In this study, we aimed to investigate the association of the rs16928751 or +795 G>A variant in adiponectin receptor 2 gene (ADIPOR2) with MASLD.
Methods: Genomic DNA was isolated from the whole blood of 130 patients with biopsy-confirmed MASLD, and 130 controls according to the phenol-chloroform extraction and ethanol precipitation approach. Then the polymorphic marker of +795 G>A was genotyped by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
Results: The +795 G>A variant met the Hardy-Weinberg equilibrium (p > 0.05) in both control and patient groups; hence, the samples had good population representativeness. The genotype count of ADIPOR2 gene +795 G>A differed significantly between these two groups. The +795 G>A „AA” genotype in comparison to the „GG” was more frequent in the patients with MASLD (p=0. 037; OR=2.24, 95%CI: 1.20–6.47).
Conclusions: To our knowledge, this study is the first one that found a significant association between the +795 G>A variant of the ADIPOR2 gene and biopsy-confirmed MASLD; nonetheless, it needs to be corroborated by further research in different populations.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Gastrointestinal and Liver Diseases

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

